• roche logo

Cervical screening and HPV news

  •  New Professional Guidelines Recognise Benefit of Genotyping HPV 16 and 18 for Cervical Cancer Prevention by Assessing Individual Patient Risk Read more...

For more information on the above guidelines, please visit www.cancer.org/cancer/news/news/new-screening-guidelines-for-cervical-cancer

Press Releases

All Roche Press Releases

 2014

  • 25th April. FDA approve's Roche's HPV test for first-line primary screening for Cervical Cancer. Read more...

 

2012

  • 23rd January. HPV testing for cervical cancer risk patients set to increase. Roche sets up co –marketing agreement with private laboratory to support greater access to HPV testing Read more...

 

 2011

  • 16th November. New research points to benefits of innovative cobas® HPV test for primary screening as England’s cervical cancer screening programme includes the test in current HPV “triage” rollout  Read more...
  • 1st April. ATHENA study shows the cobas Human Papillomavirus (HPV) Test advances the standard of care by providing valuable information on the risks associated with the genotypes which cause 70 percent of cervical cancer  Read more...
  • 17th March. New diagnostic test ‘a surer way’ of pinpointing risk signs of cervical cancer in women  Read more...

 

 2010

  • 23rd November. New Cervical Cancer Screening test set to save the lives of women all over the UK  Read more...

 

 2009

  • 14th December. New, fully automated, CE IVD approved cobas® 4800 set to help meet demand for national screening programmes  Read more...

 

Sign-up to receive updates on the cobas® HPV Test and HPV news. 


  • Acronyms: